Best Buy Reports Return to Comparable Sales Growth, Increased EPS, and Dividend Hike in Fiscal 2026 Annual Report
Summary
Best Buy reported a return to comparable sales growth and increased profitability in fiscal 2026, alongside a dividend increase and continued share repurchases, despite ongoing restructuring and impairments.
Key Events
-
Return to Comparable Sales Growth
Best Buy reported a 0.5% comparable sales growth in fiscal 2026, a positive turnaround from a 2.3% decline in fiscal 2025, driven by strength in computing, mobile phones, and gaming.
-
Increased Net Earnings and Diluted EPS
Net earnings rose to $1,069 million in fiscal 2026 from $927 million in fiscal 2025, with diluted EPS increasing to $5.04 from $4.28.
-
Dividend Increase and Share Repurchase Program
The Board approved a 1% increase in the quarterly cash dividend to $0.96 per share. The company repurchased 4.0 million shares for $273 million in fiscal 2026, with $3.0 billion remaining under the existing $5.0 billion authorization.
-
Strategic Restructuring and Best Buy Health Impairment
Restructuring charges totaled $190 million in fiscal 2026, primarily related to labor and store optimization and the Best Buy Health business. Goodwill and intangible asset impairments related to Best Buy Health amounted to $171 million, a significant reduction from $475 million in fiscal 2025.
Analysis
Best Buy's latest 10-K filing indicates a positive shift in its financial trajectory, with a return to comparable sales growth and an increase in net earnings and diluted EPS for fiscal 2026. The company's strategic initiatives, including the expansion of Best Buy Ads and Best Buy Marketplace, are beginning to show results. While restructuring charges and goodwill impairments were recorded, these were part of an optimization strategy, particularly for Best Buy Health, and the impairment amount significantly decreased from the prior year. The dividend increase and ongoing share repurchase program signal management's confidence and commitment to shareholder returns. The Supreme Court ruling on tariffs presents a potential future benefit, though its financial impact remains uncertain.
At the time of this filing, BBY was trading at $63.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $54.99 to $84.99. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.